Kaplan-Meier survival analysis by TP53 mutations in the molecular subtypes of diffuse large B-cell lymphoma. (A) Overall survival of patients with GCB-DLBCL with TP53 mutations. (B) Overall survival of patients with non–GCB-DLBCL with TP53 mutations. (C) Overall survival of patients with GCB-DLBCL with DNA-binding domain mutations. (D) Overall survival of patients with non–GCB-DLBCL with DNA-binding domain mutations.